Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Lee Hooper a MANDEC, University Dental Hospital of
Manchester, Manchester M15 6FH, b Department of Social Medicine, MRC Health Services
Research Collaboration, University of Bristol, Bristol BS8
2PR
Correspondence to: L Hooper
Objective:
To assess the long term effects of advice to restrict dietary sodium in adults with and without hypertension.
What is already known on this topic
Long term effects (on blood pressure, mortality, and morbidity) of
reduced salt intake in people with and without hypertension are unclear What this study adds
Meta-analysis shows that blood pressure was reduced (systolic by 1.1 mm
Hg, diastolic by 0.6 mm Hg) at 13 to 60 months, with a reduction in
sodium excretion of almost a quarter (35.5 mmol/24 hours) The interventions used were highly intensive and unsuited to primary
care or population prevention programmes Lower salt intake may help people on antihypertensive drugs to stop
their medication while maintaining good control of blood pressure, but
there are doubts about effects of sodium reduction on overall
health
lee.hooper{at}man.ac.uk
Design:
Systematic review and meta-analysis of
randomised controlled trials.
Data sources:
Cochrane library, Medline, Embase, and bibliographies.
Study selection:
Unconfounded randomised trials that
aimed to reduce sodium intake in healthy adults over at least 6 months. Inclusion decisions, validity and data extraction were duplicated. Random effects meta-analysis, subgrouping, sensitivity analysis, and
meta-regression were performed.
Outcomes:
Mortality, cardiovascular events, blood
pressure, urinary sodium excretion, quality of life, and use of
antihypertensive drugs.
Results:
Three trials in normotensive people
(n=2326), five trials in those with untreated hypertension (n=387),
and three trials in people being treated for hypertension (n=801) were included, with follow up from six months to seven years. The large
high quality (and therefore most informative) studies used intensive
behavioural interventions. Deaths and cardiovascular events were
inconsistently defined and reported. There were 17 deaths, equally
distributed between intervention and control groups. Systolic and
diastolic blood pressures were reduced (systolic by 1.1 mm Hg, 95%
confidence interval 1.8 to 0.4 mm Hg; diastolic by 0.6 mm Hg, 1.5 to
0.3 mm Hg) at 13 to 60 months, as was urinary 24 hour sodium
excretion (by 35.5 mmol/24 hours, 47.2 to 23.9). Degree of reduction in
sodium intake and change in blood pressure were not related.
Conclusions:
Intensive interventions, unsuited to
primary care or population prevention programmes, provide only small
reductions in blood pressure and sodium excretion, and effects on
deaths and cardiovascular events are unclear. Advice to reduce sodium intake may help people on antihypertensive drugs to stop their medication while maintaining good blood pressure control.
Restricting sodium intake in people with hypertension reduces blood
pressure
Few deaths and cardiovascular events have been reported in salt
reduction trials
Read all Rapid Responses